Peptides work through fundamentally different mechanisms than stimulant medications
Once the adipose tissue expandability exceeded limit under overnutrition, excess lipids and toxic lipid metabolites (FFA, diacylglycerol, ceramide) accumulated in non-adipose tissues, thus leading to lipid-induced toxicity (lipotoxicity) and developed IR in liver and muscle
The two molecules sit in the same melanocortin neighbourhood, but their receptor profiles, evidence bases, regulatory histories, and sourcing cautions are materially different
Semaglutide alternatives may be necessary for some to consider, including other peptide weight loss medications and appetite suppressants
Tolerance for side effects The presence and severity of side effects can influence dosage adjustments
10.1007/s11892-018-1011-7 195